Pharmaceutical Supply and Payment Chain Coalition Announces Guiding Principles for Safe, Efficacious Access to COVID-19 Vaccine

(Washington, D.C.) — Today, representative organizations of America’s pharmaceutical supply and payment chain, including prescription and over-the-counter brand and generic manufacturers; pharmacies and pharmacists across all practice settings, including health systems and hospitals, community, specialty, and managed care; supermarkets; wholesalers; pharmaceutical quality standard developers; employers and other health plan sponsors; health insurance providers; and pharmacy benefit managers, released guiding principles for the safe efficacious development, distribution, and allocation of vaccine(s) to achieve mass immunization against the coronavirus (COVID-19). 

The guiding principles represent the commitment of the private sector to the efficient, well-coordinated distribution, allocation, and mass immunization against COVID-19 as a necessary countermeasure to the current pandemic.  

Click here to read: Guiding Principles for Safe and Efficacious COVID-19 Vaccine Development, Distribution, Allocation, and Mass Immunization. 

The strong and ongoing collaboration demonstrated by the pharmaceutical supply and payment chain has been essential for a host of issues important to Americans during the COVID-19 pandemic. The coalition looks forward to continuing to work together in the best interest of the individuals and families that we serve.  

For additional information and resources on the individual efforts of each of these organizations, please see the links below. 

### 

Press Contacts:  

  • Abigail Fredenburg, Academy of Managed Care Pharmacy (@email)  

  • Kristine Grow, America’s Health Insurance Plans (@email)  

  • Meredith Jannsen, American Pharmacists Association (@email

  • Amy Ruth Cole, ASHP – American Society of Health-System Pharmacists (@email

  • Rachel Schwartz, Association for Accessible Medicines (@email)  

  • Scott Frotman, Biotechnology Innovation Organization (@email)   

  • Tess Thomson, Blue Cross Blue Shield Association (@email

  • Kathleen Ward, U.S. Chamber of Commerce (@email

  • Heather Garlich, FMI – The Food Industry Association (@email

  • John Parker, Healthcare Distribution Alliance (@email

  • Chris Krese, National Association of Chain Drug Stores (@email)  

  • Sheila Arquette, National Association of Specialty Pharmacy (@email)  

  • Andrea Pivarunas, National Community Pharmacists Association (@email

  • Laura Strange, National Grocers Association (@email)  

  • Charles Coté, Pharmaceutical Care Management Association (@email

  • Nicole Longo, Pharmaceutical Research and Manufacturers of America (@email)  

  • Anne Bell, U.S. Pharmacopeia (@email

Related